1,2,3,4-tetrahydroisoquinoline has been researched along with Alzheimer Disease in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Qin, J; Su, C; Tang, H; Wang, L; Wei, S | 1 |
| Bajda, M; Godyń, J; Hebda, M; Malawska, B; Więckowska, A; Więckowski, K | 1 |
2 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Alzheimer Disease
| Article | Year |
|---|---|
Hybrids of oxoisoaporphine-tetrahydroisoquinoline: novel multi-target inhibitors of inflammation and amyloid-β aggregation in Alzheimer's disease.
Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Animals; Anti-Inflammatory Agents; Aporphines; Butyrylcholinesterase; Cell Line, Tumor; Cholinesterase Inhibitors; Gene Expression Regulation, Enzymologic; Humans; Interleukin-1beta; Mice; Microglia; Molecular Targeted Therapy; Nitric Oxide; Nitric Oxide Synthase Type II; Peptide Fragments; Protein Aggregates; RAW 264.7 Cells; Tetrahydroisoquinolines; Tumor Necrosis Factor-alpha | 2019 |
Lipophilic properties of anti-Alzheimer's agents determined by micellar electrokinetic chromatography and reversed-phase thin-layer chromatography.
Topics: Alzheimer Disease; Cholinesterase Inhibitors; Chromatography, Micellar Electrokinetic Capillary; Chromatography, Reverse-Phase; Chromatography, Thin Layer; Drug Discovery; Humans; Hydrophobic and Hydrophilic Interactions; Indoles; Lipids; Phthalimides; Tetrahydroisoquinolines | 2017 |